What Great News! Embryonic Stem Cells Unnecessary!

With the controversy surrounding the use of embryonic stem cells, the above headline may come as a shock. The recent veto by President George Bush that denied extra federal funding for research conducted on embryonic stem cells, along with the clamor and backlash the decision faced from scientists, politicians, and various institutions, has all but confirmed the importance of embryonic stem cells. Is that not right? Perhaps not, as commentator Pat Boone recently found out. The fact is, embryonic stem cells may not be as important as we all think.

A couple of months ago, I was in downtown Los Angeles, at the courthouse, doing my jury duty for several days. There are always breaks and lulls, during which time hundreds of participants can and do talk and get to know each other. I actually enjoyed it.

During one of those breaks, I was electrified by a conversation with an L.A. scientist/engineer/businessman named John. Somehow the subject of embryonic stem-cell research came up, and I expressed my deep concerns about the eventual creation of nascent embryos and then the use of them in laboratory experiments. The state of California recently committed 3 billion taxpayer dollars, over the strenuous objections of many of us, to this experimentation.

Boone thinks like many of us today, that embryonic stem cells hold some sort of key to all our ailments. However, the moral dilemma that many individuals have with using embryos fuels the controversy. It seems as if the only thing keeping us from making great medical strides and developing advanced and effective treatments for illnesses that are incurable, is money to do the research needed to find the answers, and the elimination of any moral and religious debate. This has been the underlying principle behind embryonic stem cell research as Boone describes.

The rationale, the hope, is that pure embryonic stem cells might be effective in treating dire conditions like Parkinson’s, cancer, epilepsy and Alzheimer’s disease. There’s no proof, just the hope and projections of eager scientists and many large medical companies, and the very understandable desire of so many whose lives are affected by these and other maladies. The yearnings to find cures, somehow, somewhere, are overriding the moral questions about actually fertilizing a human egg with a human sperm, creating a life (obviously, if the new creation isn’t living, it’s useless) – and then dissecting and short-circuiting the inevitable development of this living organism in a search for a possible cure-all.

John continued to explain to Boone what his company specialized in. Dr. John said that it was non-controversial stem cells and treatment. He told Boone about the research that they had done and in detail pointed out the differences between embryonic and non-embryonic stem cells. Boone’s commentary below shows his amazement at what he heard. Because like many of us today, he was led to believe by the media and hype surrounding embryonic stem cells, that they were the only answer and that any moral dilemmas any of us face would have to be sequestered.

John told me about his company, a Los Angeles based adult stem-cell company whose goal is to develop stem-cell products for the life science and health-care industries. He informed me that the scientific founders of this company have over 30 years of experience in stem-cell research –and that they have discovered a novel stem cell from adult tissues with properties similar to cells obtained from embryos! These cells can be – and are being – recovered from almost any tissue found in adult humans, while maintaining many of the properties described for embryonic stem cells!

I was astounded.

John went on to tell me about the research conducted all these years by Dr. H and his colleagues in laboratories in Georgia, demonstrating scientifically that postnatal individuals – that’s you and me – contain a series of adult stem cells with attributes very similar, but not identical, to stem cells derived from embryos and fetuses. The similarities between these two groups of stem cells, i.e., embryonic stem cells and adult stem cells, include an unlimited ability to increase in numbers (self-renewal) and their ability to form any cell type in the body, including the gametes.

John continued to outline the discrepancies between the two forms of stem cells, and went on to state that a person could even use their own stem cells harvested from their own body. This would be ideal since they would be an exact match for the patient right down to the very DNA, and eliminate any chance of rejection.

The differences noted between embryonic and adult stem cells are reflected in the programming of the cells. The former cells are pre-programmed to form all the tissues of an individual. This event occurs automatically after conception, with fusion of the reproductive gametes, the sperm and ovum. In contrast, adult stem cells are not preprogrammed to form anything; they wait for exterior or environmental signals to tell them what they should do. They’re in a “resting state,” in effect waiting for marching orders. And Dr. H demonstrates, in a powerful photographic presentation that my wife and I have seen, that his group can – and have – identified and utilized specific chemical agents that can tell adult stem cells to form a specific single cell type, which they will do. And then those cells can be injected into the blood stream, where they will seek and find the damaged place where they’re needed!

And, wonderfully, a patient’s own easily harvested adult stem cells can be used for his or her own treatment, and the implanted “self” stem cells will not be rejected! In the presentation Shirley and I saw, we observed these powerful cells go like homing pigeons to the most needed spots in the heart or brain or other vital organ of the donor – and repair the damage. It looked truly miraculous, and we believe it is.

Boone finished his commentary by once again discussing the moral issues surrounding the use of embryonic stem cells. But there is an alternative as Boone learned. All the benefits of stem cell therapy, without any moral issues to hold science back. Boone even cites biblical passages in the end to point out that the bible, the foundation of the morals that drive many to oppose embryo use, may have been trying to tell us what all along what now seems to be an answer.

We’re not doctors or scientists and can only partially grasp all we’re seeing and hearing about. But to us, what these qualified and experienced scientists have discovered and developed not only makes the very expensive, long-range and extremely questionable research and use of created embryos unnecessary, it also offers help and probably miraculous treatment much more imminent and abundantly available, without the moral dilemma.

It reminds me of the time Moses balked at God’s command to confront Pharaoh with His command “Let My people go!” Moses felt so inadequate and asked, “Why should Pharaoh listen to what I say?” And God answered, “What is that in thy hand?”

Moses, befuddled, said, “My staff, my walking stick … Why?” God told him to throw it on the ground, and it became a serpent. Then God told him to pick it up, which Moses gingerly did, and it was a staff again. The point was the Creator of all mankind can do anything He wants, and we’re created in His image, with infinite capabilities. Instead of trying to “play God” and tamper with His proprietary creative processes, I feel we should recognize that He’s asking again, “What is that in your hand, in your blood? Use that, and I’ll work with you. Leave creation to me. I’ve got a lot more experience than you do!”

Non-Controversial Stem Cell Research Thrives

Emily was born June 6, in Northwest Medical Center in Broward County, her parents and her doctor gave her a special gift. Among the earliest in the nation to do so, Emily’s parents, Matt and Rosa of Margate, Fla., banked stem cells collected from the placenta that surrounded their baby before her birth.

An option that has been available for several years, blood from her umbilical cord was collected and saved. The blood can be used to effectively treat several serious blood and immune system diseases.

Although stem cell debate has escalated in recent years, a non-controversial source could present potentially life-saving therapies. Scientists discovered certain cells from the placenta may be as versatile as human embryonic stem cells.

Placental-derived stem cell research is likely to accelerate since President Bush vetoed the recent bill that would have increased federal funding for embryonic stem cell research. Placental stem cells are eligible for federal funding and in many ways more ideal due to the fact that they behave like embryonic stem cells, are plentiful, and do not involve the destruction of human embryos.

Recent accomplishments support the science behind placental stem cell research.

Scientists have been able to coax the placental stem cells to become bone, nerve, muscle, fat, pancreatic, or liver cells, which could make them useful in future treatment of such ailments as diabetes, heart disease, Alzheimer’s, and Parkinson’s.

“I know that with the cord blood, they have been able to treat leukemias, lymphomas, and anemias,” said Rosa, “but with the placenta cells, they’ll be able to treat heart disease, liver disease, diabetes, neurological disorders and do bone regeneration, and probably things we don’t even know about yet.”

Rosa and her husband want extra protection for their first child Emily in case something goes wrong in the future. Thus, banking her cord blood and placental tissue was the obvious choice. Mary, who is a surgical technician at the hospital where her daughter was born, also stated that cells also may be helpful to other family members because of the close genetic match.

“Being in the medical field, I’ve had a chance to see all kinds of things I wouldn’t want my daughter to go through,” she said. “With the cord blood and the placenta, you’re covered for anything. Life insurance is one thing, but this is kind of like life assurance.”

Dr. Bruce, the ob-gyn who delivered Emily by C-section and extracted the placental tissue and umbilical cord blood, said stem cells from cord blood have already saved many lives, and the placental cells offer promise for the future.

Mother to Bush – Son is Symptom Free Due to Stem Cell Treatment

Mary and her family, in the midst of another two dozen families, met with President George Bush before he signed two bills and vetoed another connected to stem cell research.

During a 15 second photo op, Mary tried to tell the story of her 3-year-old son. Ryan who suffers from mild cerebral palsy, she told the president, was the first child in the nation to be injected with stem cells from her own umbilical cord blood.

Her son received the infusion and immediately showed significant signs of improvement. Since October, the Batavia mother has tried to spread the story of her son to the masses, and now she had the chance to tell President Bush.

“I said, ‘My son is symptom-free now,’ and he just was floored. He just was speechless,” Mary said. “His mouth went open and he said, ‘What? Really?'”

Bush was quite interested in what Mary had to say, judging by the way he tried to follow her before he was pulled back by his staff, Mary stated.

A year prior to their child’s birth, Mary and her husband Steve decided to bank her cord blood and save Ryan’s umbilical cord after learning the significance of stem cells. One of Mary’s family members had died of leukemia because they were unable to find a compatible match of bone marrow, another source of stem cells.

Stem cells derived from cord blood (a rich source for stem cells), have revealed that they can differentiate into other varieties of cells in the body. Cord blood, used for many years as a cancer treatment was used in unique circumstances. Ryan’s case was the first where the stem cells were being used to treat a neurological disorder such as cerebral palsy.

Since there is no way to track if the stem cells are in fact the cause of health improvements, physicians and researchers are tentative to endorse the procedure says Mary. She finally went to an agreeing physician at Duke University in North Carolina after months of probing and rejection for the treatment from other clinics and doctors.

“Now he talks fine, he has no feeding issues, he has all his mobility back. There’s no need for occupational or speech therapy — he’s signed up for swim class,” she said.

Ryan no longer has the disorder according to evaluations by the Easter Seals and neurologists, Mary said.

“I’m grateful every single day. He isn’t even aware of what he was missing and what he’s gotten back. It’s so cool he’s got all these options and abilities in life now,” his mother said.

Anxious to get the word out, she has called legislators and “raised some eyebrows,” landing her an invitation to speak at a press conference about stem cell research in Washington, D.C., last month. Mary met with several senators, and Ryan’s story was brought up on the Senate floor by both Senators Barack Obama, D-Ill., and Sam Brownback, R-Kan.

In her pursuit to accomplish her goal of informing families around the nation about the magnitude of cord blood, she looked at her meeting with the president as the first step in her journey.

“For my family, they were awestruck. For me, it was, ‘This is my chance, this is my 15 seconds to get the message out for these families and these kids,'” she said. “I was on a mission.”

Upon returning Batavia, Mary plans to work on launching her foundation — www.neurocordblood.org — which will supply information about cord blood banking.

“The abilities you can have with this are just astounding,” she said. “It’s going to help so many kids.”

Girl Flies to China for Stem Cell Treatment

Sacha, a five-year-old girl afflicted with the rare Batten Disease, is to have pioneering stem cell surgery in Shenyang, northern China. The procedure will consist of weekly spinal column injections, each comprised of 10 million stem cells, for the duration of one month.

Taken from umbilical cords with the permission of new mothers, blood stem cells will be injected into Sacha’s spinal column and will move through the blood stream to the brain, where it is hoped they will start to fix the damage caused by Batten Disease.

The illness has left her incapable of walking or talking without assistance and Sacha’s family is hoping the experimental treatment reverses the effects of the disease which attacks the central nervous system.

Batten disease has no cure and affects one in every 30,000 children that are bon in the UK. Diagnosed last July, Sacha is not expected to live past the age of 12 without treatment.

Sacha’s mother Annette, while researching the disease online, made contact with a Swedish woman whose son had undergone the procedure in China.

She visited her earlier this month and was encouraged by the improvement the boy had made.

“This is the first time I have heard of a child showing signs of improvement anywhere in the world,” said Annette, 37. “They are not huge changes but all his nurses and his mother have noticed a definite improvement which is very exciting and encouraging.”

On August 12, Annete will fly out with Sacha for the treatment, returning to the UK a fortnight later when Sacha’s father, Neil, arrives.

More trips to China may be necessary for Sacha if the initial treatment proves successful.

Other alternatives included brain surgery in America but Sacha was unable to have the operation after her severity of her seizures increased.

Her stomach was fitted with a tube to allow her mother to give her fluids and medicine as her condition progressively became worse.

Earlier this year Sacha was recognized for her courage in The Argus Achievement Awards.

“Sacha is still taking food orally but only just. Her swallowing mechanism is going and we have to puree everything,” said Annette, “I am feeling really positive about the treatment. I don’t feel nervous at the moment but I might do on the plane over there.”

“Sacha isn’t going to have brain surgery which I was worried about and this isn’t as invasive,” added Sacha’s mother, “I’m looking forward to the future whereas before I just didn’t think we had any hope.”

Hove businessman Chris funded the treatment by donating £10,000 to Sacha’s family after reading of her illness in The Argus.

Annette said: “We are so grateful to Chris. Without him none of this would be possible.”

Safety of Spinal Cord Stem Cell Transplant Established

According to University of California – Irvine researchers, transplanting stem cells is not harmful and can serve as a therapeutic approach for the treatment of severe spinal cord injury.

The study conducted by Hans a UCI neurobiologist, and his colleagues at the Reeve-Irvine Research Center confirms previous findings by Hans’ lab; that replacing a cell type lost after injury improves the result after spinal cord injury in rodents. Identical data published by four other laboratories in the world show that rats with either mild or severe spinal cord injuries that were transplanted with using stem cells as a treatment suffered no visible injury or ill effects as a result of the treatment itself.

In 2005, Hans’ lab was the first to persuade stem cells to become highly pure specialized cells known as oligodendrocytes. The cells are imperative for the maintenance of electrical conduction in the central nervous system and also serve as the raw materials of myelin which acts as an insulation for nerve fibers. Paralysis can result when myelin is lost through disease or injury.

The current study, just like the original, exhibited that rats suffering from severe spinal cord injury injected with oligodendrocytes seven days after the injury, had the cells migrate to the proper sites within the spinal cord and wrap around damaged neurons, forming new myelin tissue.

In comparison, rats that were only slightly impaired showed no change in walking ability after transplantation or an increase or decrease in myelin generation. Hans says this is due to the fact that no loss of myelin occurred. Thus, any treatment targeted at regenerating myelin would have no effect because the animals were able to recover motor functions on their own, due to the minor nature of the injuries. It is important to note that although the treatment did was not able to provide ay benefit, it also did not cause any harm. Scientists decided to examine further and found no signs of damage to the tissue surrounding the spinal cord, thus demonstrating that no damage had occurred due to transplantation in the animals.

“Establishing the safety of implanted stem cells is crucial before we can move forward with testing these treatments in clinical trials,” said Hans an associate professor of anatomy and neurobiology and co-director of UCI’s Stem Cell Research Center. “We must always remember that a human clinical trial is an experiment and, going into it, we need to assure ourselves as best as we can that the treatment will not cause harm. This study is an important step in that direction.”

Hans is working with Geron Corp. to bring this treatment for acute spinal cord injury into Phase I clinical trials within the next year.

“Our biggest safety concern was that in the case of a severe injury, any harm the stem cell-derived treatment could cause would be masked by the injury itself,” Hans said. “In this study, we can see in animals that are only slightly injured that the transplantation does not cause visible harm and the injury is not hiding any damage the cells may have caused to the spinal cord or the surrounding tissue.”

UCI is a premier center for stem cell research in California. The university announced last week that it had received a $10 million gift from Bill and Sue in support of stem cell research, including matching funds to construct an $80 million Stem Cell Research Center facility.

Human Hair Follicles Source for Multipotent Stem Cells

Study co-authors are Hong Yu, Suresh M. Kumar, and Geza Acs, all from Penn; and Dong Fang, Ling Li, Thiennga K. Nguyen, and Meenhard Herlyn, all from the Wistar Institute, Philadelphia., University of Pennsylvania School of Medicine, July 12, 2006

New sources of adult stem cells appear to have the potential to differentiate into several cell types. Isolated by researchers at the University Of Pennsylvania School Of Medicine, the cells could one day provide the tissue required by individuals for treating a multitude of disorders. However, the approach to growing the cells must be put into overdrive to combat diseases such as Parkinson’s, spinal cord injury, and peripheral nerve disease.

“We are very excited about this new source of adult stem cells that has the potential for a variety of applications,” says senior author Xiaowei, MD, PhD, Assistant Professor of Pathology. “A number of reports have pointed to the fact that adult stem cells may be more flexible in what they become than previously thought, so we decided to look in the hair follicle bulge, a niche for these cells.” Xiaowei and colleagues report their findings in the latest issue of the American Journal of Pathology.

The researchers used an environment equal to that in human embryonic stem cell culturing. After isolating the cells from hair follicles, which were already a well known source of adult stem cells, researchers were able to grow a new type of multipotent adult stem cell from the scalp tissue provided by the National Institute of Health’s Cooperative Human Tissue Network.

Investigators gave the name “hair spheres” to the multipotent stem cells which grow in masses. They were able to separate the stem cells into multiple lineages after growing the “raw” cells from hair spheres using different varieties of growth factors. The lineages included nerve cells, melanocytes, and smooth muscle cells.

“Although we are just at the start of this research, our findings suggest that human hair follicles may provide an accessible, individualized source of stem cells,” says Xiaowei. The researchers are now working on inducing other cell types from the hair sphere cells and testing the cells in animal models.

Study co-authors are Hong, Suresh, and Geza, all from Penn; and Dong, Ling, Thiennga, and Meenhard, all from the Wistar Institute, Philadelphia.

Stem Cell Research to Combat Australia’s #1 Killer

Cardiovascular disease is Australia’s number one killer, but those afflicted by the disease may soon have optimism due to research conducted in Adelaide using stem cells.

Cells harvested from their own bone marrow will give patients a new treatment options utilizing purified stem cell technology.

While this new technology, which aims to create new heart tissue, is not intended to substitute current methods of treatment, it does give physicians another alternative for those patients who have not successfully responded to normal protocol which includes medication, surgery, and pacemakers.

The research, funded by the National Heart Foundation, is unique because of the high purity stem cells that are extracted from the bone marrow.

“There has been quite a lot of work in developing purification techniques with bone and cartilage, but its use in cardiac research is really only beginning,” stated cardiologist Dr. Peter.

“Previously human cells were injected into rats that had had heart attacks and the damage was reversed or repaired a lot by new blood vessels formed in the heart.”

Six months into the study, Dr. Peter said the team had already noted promising results.

University of Adelaide’s Professor Stephen, Dr. Andrew, and Dr. Stan from the Hanson Institute are part of the team at the Royal Adelaide Hospital.

The doctors intend to test the technology in larger animals first, such as sheep, and in two to three years begin clinical trials with human subjects.

“Should the treatment become available worldwide we would be looking at a 5-10 year time frame,” Dr. Peter said.

Adult Stem Cells Help to Prevent Amputation

Peripheral arterial disease, recognized as PAD, is a vascular disorder that affects the blood circulation in the arms, legs, feet, stomach, and kidneys. Normally a disease that requires amputation of the affected body part, Indiana University doctors are pioneering a novel method to prevent and avert such permanent treatment using a patient’s own stem cells.

The researchers at IU harvest adult stem cells from the patient’s bone marrow, inject the cells into the diseased leg, and thus encourage the development of new blood vessels and correct the problem. The study conducted by scientists at IU is the only one of its kind in the United States.

According to scientists, in patients that are healthy, stem cells from the bone marrow migrate out of the tissue to repair arteries and organs when they are injured. For individuals afflicted with PAD, stem cells cannot reach the injured tissue in numbers that make a difference.

Thus, in patients suffering from advanced PAD, doctors at IU decided to try transporting the healing stem cells from the marrow to the leg.

The results look hopeful even though to date, only 10 patients have gone through the procedure.

“The information that we’re getting from this study is telling us this therapy does indeed work, and we’re learning more and more about how to isolate this information,” said Dr. Michael, an assistant professor of surgery at Indiana University School of Medicine and the principal investigator of the trial.

PAD, a hardening and clogging of the arteries that can lead to poor circulation, pain, and numbness on the legs and feet, afflicts between 8 and 10 million people. In about 10 percent of the patients, PAD symptoms become so bad that amputation may be the only standard treatment option available stated Murphy.

Other present methods of treatment include angioplasty and/or bypass surgery to avoid the eventuality of amputation, but the downside is that not every individual patient is suitable for one of these procedures.

Michael’s study offers an option to those individuals where amputation is the only choice left.

Four years ago, 23 year old mother and dietary aide Adriane lost all five toes on her right foot after PAD developed when she had a blood clot in her leg. When PAD caused difficulty in her other leg, Adriane feared another amputation.

After registering in Michael’s trial in September, she has no problems. The discolorations and swelling in her foot, the pain, all of these disappeared.

“Now I can do everything I want,” she said. “I was worried, because I had been there before and I knew what the outcome was in the end. I was worried I would have to go through something like that again.”

The eventual goal is to enroll 20 patients in the study and conduct follow-ups for at least one year following treatment. Michael and his colleagues have had patients come from Miami, Kansas, and New York for the procedure.

A second study on PAD has been planned where the efficacy of stem cells isolated from a patient’s fat tissue will be compared to those cells that come from bone marrow. Michael also planned an exploration into whether they might also avoid hardening of arteries, not just in PAD, but throughout the body. The exploration would begin once either or both of the techniques for treating PAD are confirmed a success.

“We’re hoping to expand this information to rebuilding the heart after a heart attack, the brain after a stroke, and maybe even the kidney or liver with the complications of diabetes,” Michael said.

MS Sufferer Scott to Undergo Cord Blood Stem-Cell Treatment

Twenty-seven year old Scott from Balby in the UK has suffered from multiple sclerosis most of his life. However, today Scott is on his way to Holland to undergo the first stage of a stem-cell based treatment that he hopes will transform his life and defeat his terminal illness. Unable to feed himself and confined to a wheelchair, Scott hopes the injections will help him walk again.

Scott’s mother, Sue, said: “We know there are no guarantees with this treatment, but we realize it’s the best chance Scott has.”

The treatment involves three days of intense therapy, and patients that decided to undergo the procedure claim their condition significantly improved.

Scott could start to experience therapeutic benefits within months.

In the Dutch city of Eindhoven, Scott is set to receive “aqua tilis” therapy in a clinic today. The procedure requires Scott to sit in a cabin for approximately half an hour while being surrounded by water vapor which will enter his body’s pours, a process which facilitates detoxification and increases the chances of the stem-cell treatment being successful.

Scheduled for tomorrow at a clinic in Rotterdam, Beanlands’ appointment will involve injections of umbilical cord blood stem-cells into his body.

The hope is that the healthy stem-cells will replace the diseased or dysfunctional ones in Scott’s body, and become a new life-long repair system.

The treatment costs £13,000, much of which was raised by Leicester Mercury readers after we first told Scott’s story.

Experimental Procedure Brings Hope to Man

Steve wasn’t wearing a seatbelt. Two of the discs in the cervical region of his spinal cord were shattered. His skull, smashed against the car’s door jam. Steve left the intensive care unit at Christiana Hospital as a tetraplegic, with complete or partial paralysis in all four limbs.

It all happened on Feb. 18, 2001 as he headed home from his relatives house in southeastern Pennsylvania, south on Limestone Road toward Pike Creek. It was just before 4:30 a.m. as he drifted off to sleep and off the road, striking head on into a utility pole causing several power outages in the area.

No one could have predicted what was to happen that night, but Steve’s injuries could have been much worse. Presently he has some strength in his arms, hands and fingers. He can even drive, although in a specialized 2002 Dodge Caravan. Within the 8 months following the accident, he was back at work in Delaware. Steve was a senior motor vehicles technician at the Department of Motor Vehicles in New Castle.

Steve made strides in his progress following the accident, but soon Steve, now 37, may be able to do even more.

At the Hosptial de Egas Moniz in Lisbon, Portugal, Yaros underwent an olfactory mucosa autograph – a type of stem cell surgery. Cell tissue was extracted from the uppermost part of Steve’s nasal cavity and transplanted into his spinal cord. Researchers believe that the transplanted stem cells in this procedure can help repair a damaged spinal cord.

“It seems like these cells have the same potential in terms of forming a variety of cell types, just like embryonic stem cells,” said Jean, an associate professor at Wayne State University Medical School in Detroit.

The operation is not approved by the U.S. Food and Drug Administration, thus facilitating the need for Americans to go outside the country for treatment. At a cost of almost $45,000, 40 individuals from the United States and more than 80 worldwide have undergone the procedure.

Steve would love to be able to walk again, but he has stated that even minor improvement would be worth it. For example, his grip has been so weak that it is difficult for him to get him cash withdrawal card out of the ATM machine.

“I can’t even tear a piece of paper,” he said before leaving for Portugal.

He learned about the stem cell procedure last year from a friend. A few months ago, he flew to the Rehabilitation Institute of Michigan in Detroit, where a doctor evaluated his X-rays, his physical abilities and his mental health to determine if he qualified for the surgery.

“We give people the pros and the cons,” said Cheryl, a spokeswoman for the institute. However, “we don’t endorse it,” Cheryl also stated.

Since Steve was under 40 and it had been less than 6 years after the accident Steve was a candidate for the surgery. Also helping was the fact that the length of his injury was only 1 centimeter.

“As soon as he found out that he could go, we started raising the money,” Steve’s boss Marion said. “Anybody who knew him donated things or money because we all love him.”

He credits his parents, John and Ruth, and his brother Mark for taking care of his nursing needs since the accident. He’s also appreciative to his employer and his co-workers. Steve can park his minivan in a handicap-accessible space that was created for him. A fund-raising effort — Friends of Steve — spearheaded by his boss Marion, helped raise $39,000 for the operation. (His family covered the remaining costs). The Friends of Steve effort will carry on over the next year to help raise money for therapy costs and equipment.

Steve will return to the United States a week from today, where he’ll begin rehabilitation. To him, the trip and the surgery are worth the risks.

“If I didn’t do this,” he says, “I’d regret it.”